RebelBio calls on engineering entrepreneurs to apply for life-science funding
31 January 2017
RebelBio (formerly SYNBIOAXLR8R – the world’s first commercial accelerator programme for life sciences) is now accepting applicants for its Cork-based programme.
RebelBio has moved beyond the niche field of synthetic biology into the open-ended space of life sciences and technology. As with all SOSV (The Accelerator VC) programs, the programme is open to applicants from all over the world. RebelBio offers seed funding, lab space and world-class mentorship.
RebelBio welcomes applications from citizen scientists, biohackers and bio-entrepreneurs of any skill level – from undergraduates to experienced postdoctoral researchers – to take part and democratise biotechnology so we can impact society for the better, faster, Priority is given to independent startups and a PhD, although respected, is not a prerequisite to become part of this fast-paced programme.
Applications are currently open with deadlines being extended to 1 March 2017.
The programme is three months long with a an additional one month pre-programme in business skills at the front end. The business pre-accelerator is designed to prime science-based startups for the realities of the business environment. The summer accelerator begins in April and continues until July, when companies will showcase their emerging businesses at Demo Day.
Ireland is of strategic interest to emerging startups as one of the only English-speaking economies with strong ties with the United States, the UK and the rest of Europe. It is also an attractive business base, due to its 12% corporate tax rate – meaning active subsidiaries are tax-free for two years with 12.5% being applied thereafter.
Research-focused companies can avail of even lower rates around 6.5%. The prospect of being able to build companies in a low cost, knowledge-based economy strengthens Ireland’s position as a leader in startups. With support and partnership from University College Cork, SOSV and sister accelerator IndieBio in San Francisco, RebelBio startups are uniquely placed to create a global impact in both economic and societal terms, resulting in jobs and exports for the wider economy.
For application details and more information, please visit www.rebelbio.co.
SOSV — The Accelerator VC — is a venture fund with US$250 million AUM operating global accelerator programs: HAX for hardware in Shenzhen and San Francisco, RebelBio for biotech in Cork, Ireland, IndieBio for biotech in San Francisco, Chinaccelerator for Internet in Shanghai, FOOD-X for the business of food in NYC, MOX for mobile software in Taipei, and URBAN-X for smart cities in NYC. SOSV invests in over 150 companies per year and over its two-decade history has a net IRR of over 30%, putting it in the top 7% of VC funds in the world.http://www.engineersjournal.ie/2017/01/31/rebelbio-seeks-budding-entrepreneurs/http://www.engineersjournal.ie/wp-content/uploads/2017/01/RebelBio-1024x683.jpghttp://www.engineersjournal.ie/wp-content/uploads/2017/01/RebelBio-300x300.jpgNewsfunding,research,UCC